Research Paper Volume 13, Issue 15 pp 19575—19586
Plasmatic exosome-derived circRNAs panel act as fingerprint for glioblastoma
Figure 3. The ROC curve based on risk score analysis for predicting GBM from healthy population. (A) ROC curve analysis was conducted for discrimination between GBM patients and control group in training set. Each group including 20 samples. (B) ROC curve analysis was conducted for discrimination between GBM patients and control group in validation set. Each group including 100 samples.